Arnold L. Oronsky's most recent trade in KalVista Pharmaceuticals Inc was a trade of 7,000 Director Stock Option (right to buy) done . Disclosure was reported to the exchange on Oct. 1, 2020.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| KalVista Pharmaceuticals Inc | Arnold L. Oronsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 7,000 | 7,000 | - | - | Director Stock Option (right to buy) |